Story
Deckers Stock Slides on Weak Full-Year Outlook and Decelerating Growth

Summary
Shares of Deckers Outdoor are trading sharply lower after the company issued a disappointing full-year forecast that overshadowed a mixed fiscal first-quarter earnings report.
Shares of Deckers Outdoor Corp. (DECK) fell significantly on Friday after the footwear company's full-year financial outlook disappointed investors, raising concerns about slowing growth and margin pressures despite reporting record quarterly revenue.
Guidance Overshadows Q1 Results
For its fiscal first-quarter 2027, Deckers reported mixed results. While revenue hit $1.02 billion for the first time in a single quarter, matching estimates, the company's guidance for the full fiscal year fell short of Wall Street's expectations.
Management provided the following outlook for fiscal year 2027:
- Earnings per Share (EPS): A range of $7.35 to $7.50, with the high end merely matching the analyst consensus of $7.50.
- Revenue: A range of $5.86 billion to $5.91 billion, which was at the low end of market expectations.
Underlying Concerns Emerge
AdInvestors looked past the headline quarterly EPS beat of $0.94 versus a $0.87 consensus, as underlying details pointed to weakening fundamentals. The company's net income actually declined 6.6% year-over-year to $130 million, indicating the EPS beat was primarily achieved through a reduced share count from stock buybacks rather than organic profit growth.
Furthermore, growth at its key brands showed signs of deceleration. HOKA net sales increased 7.7% and UGG sales rose 4.9% — solid figures, but a notable slowdown from the double-digit growth rates previously seen. Deckers also signaled continued margin pressure, raising its tariff assumption for the year to 12.5%.
Market Reaction
The stock's decline was company-specific, occurring while the broader S&P 500 index was trading slightly higher. The combination of a weak top- and bottom-line forecast, decelerating brand momentum, and persistent margin headwinds prompted a sharp selloff from investors.
Read next
More on Stocks
Nanexa Shares Soar Over 100% After Securing Licensing Pact with Novo Nordisk
Shares of Swedish biotech firm Nanexa AB surged after it announced a global licensing agreement with Novo Nordisk potentially worth up to €1.165 billion for its PharmaShell drug-delivery platform.

IREN Stock Slides as Competitor's IPO Filing Pressures AI Infrastructure Sector
Shares of IREN slid more than 5% amid a sector-wide selloff in AI cloud providers, sparked by a competitor's IPO filing that has raised investor concerns over valuations and pricing power.

Super Micro Computer Stock Climbs on NVIDIA Vera Rubin System Shipments
Shares of Super Micro Computer advanced after the company announced it began shipping its new liquid-cooled rack systems featuring NVIDIA's latest Vera Rubin architecture, a key milestone for its AI infrastructure business.

Celestica Stock Climbs on Pre-Earnings Optimism and Positive Analyst Sentiment
Celestica shares gained nearly 1% as investors positioned ahead of late October's Q3 earnings report and Investor Day. The advance is supported by positive analyst ratings and a strong market narrative around the company's role in AI infrastructure.